Innocore Sales & Marketing Inc
FDA inspection history across 2 sites, 2019 to 2025
- 1
- Warning letter
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2019: one Form 483; 2025: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2019One Form 483, at Woodstock, Canada.
- 2025One warning letter, at Cleveland, Ohio.
Cited most
Across all Innocore Sales & Marketing observations on file
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.115Reprocessing1
- 21 CFR 211.125Labeling issuance1
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.166Stability testing1
The complete Innocore Sales & Marketing file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Cleveland, Ohio
One warning letter · 2025
Latest: Warning letter, Oct 16, 2025 →Woodstock, Canada
One Form 483 · 2019 · 12 observations
Latest: Form 483, Jun 6, 2019 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-10-16 | Warning letter Warning letter | Cleveland, Ohio | — | $99 |
| 2019-06-06 | 483 Form 483 | Woodstock, Canada | 12 | $99 |
Investigators on these documents
FEI number 3010034070 · most recent document Oct 16, 2025
About Innocore Sales & Marketing Inc
How many FDA Form 483s has Innocore Sales & Marketing Inc received?
FDA Intel has 1 Form 483 on file for Innocore Sales & Marketing Inc; the most recent is dated Jun 6, 2019.
When was Innocore Sales & Marketing Inc last inspected by FDA?
The most recent FDA inspection document on file for Innocore Sales & Marketing Inc is a Form 483 dated Jun 6, 2019, for the site in Woodstock, Canada.
What did FDA cite at Innocore Sales & Marketing Inc?
The regulations cited most in the observations on file for Innocore Sales & Marketing Inc are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.115 (Reprocessing), 1 time; 21 CFR 211.125 (Labeling issuance), 1 time.
Has Innocore Sales & Marketing Inc received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Innocore Sales & Marketing Inc; the most recent is dated Oct 16, 2025.